Article Details
Retrieved on: 2022-01-04 13:15:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SciSparc Ltd is engaged in the drug development programs SCI-110 for treating Tourette Syndrome and obstructive sleep apnea, SCI-160 for treating ...
Article found on: www.digitaljournal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here